(877) 505-4777| info@speakersnetwork.com


Assistant Clinical Professor of Hematology Oncology
City of Hope National Medical Center


Ahmed M. Aribi, M.D., joined the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope as an assistant professor and staff physician. Before coming to City of Hope, Aribi was an instructor within MD Andersons Department of Leukemia, Division of Cancer Medicine. Aribi completed fellowships at University of California, Los Angeles and MD Anderson, and before that was a resident and intern at Southern University in Springfield, Ill. He received his medical degree from Alfateh University School of Medicine in Libya. He is board certified in internal medicine and holds medical licenses in both California and Texas

Assistant Clinical Professor of Hematology Oncology
City of Hope National Medical Center

Bone Marrow Transplant
Hematopoietic Cell Transplantation

Amandeep Salhorta, M.D.,has joined City of Hopes Department of Hematology and Hematopoietic Cell Transplantation as an assistant professor following completion of his bone marrow transplant fellowship here at City of Hope.Dr. Salhotra received his Bachelor of Medicine and Bachelor of Surgery degree, as well as his medical doctorate in pediatrics from the Maulana Azad Medical College at the University of Delhi in India. He went on to serve as senior resident in pediatrics at the All India Institute of Medical Sciences in New Delhi, followed by a research fellowship in neuro-oncology at Johns Hopkins Hospital in Baltimore, MD. He then pursued a residency in internal medicine, and a hematology-oncology fellowship at St. Elizabeths Medical Center in Boston, MA. This was followed by an additional hematology-oncology fellowship at University of Virginia Medical Center in Charlottesville, VA, before coming to City of Hope in 2012.Dr. Salhotra received the Arnold P. Gold award for Humanism and Excellence in Teaching during his residency in internal medicine (2009), and the Farrow Fellowship award for translational cancer research in 2011, during his hematology-oncology fellowship. He has published nine articles in the peer-reviewed literature and 12 abstracts. He has been invited to speak at many national and international meetings.

Associate Chair and Associate Professor, Radiation Biology
City of Hope National Medical Center

Targeting Cancer with a Lupus Autoantibody

Dr. Lius laboratory aims to understand how defects in DNA synthesis and repair contribute to cancer pathogenesis and aging. Specifically, her team focuses on a set of proteins belonging to the RECQ family of DNA helicases are among the cancer suppressors linked to DNA repair, replication and genome maintenance. During the course of evolution, RECQ genes appear to have been amplified and diverged from a single copy of the RecQ gene in bacteria and yeast to five RECQ homologs in humans. The human RECQ proteins share many similar biochemical properties in vitro, yet these proteins are not redundant, as mutations in different RECQ proteins lead to different clinical syndromes including premature aging. In addition, a defect in one RECQ protein is sufficient to cause cell transformation and tumorigenesis, and this defect cannot be compensated by other RECQ proteins. Dr. Lius long-term agenda in dissecting the functions of individual RECQ proteins in human cells and comparing the similarities and differences among the RECQ proteins is to understand what aspects of genome maintenance and DNA metabolism are required for normal development and cancer prevention.

Division of Medical Oncology and Hematology
Department of Medicine
Professor Emeritus of Medicine

Anemia in the Elderly
Anemia: Diagnosis and Management
Approach to Anemia: Cost Effective Workup
Thrombocytopenia: Diagnosis and Management
ITP – Immune Thrombocytopenic Purpura
Hereditary Spherocytosis and Related Disorders
Polycythemia: Diagnosis and Management
Sickle Cell Disorders
Hemolytic Disorders: Diagnosis and Management

Very Good Speaker – Downey Community Hospital

Clinical Professor of Medicine
Division of Hematology Oncology

New Approach to Workup of Hypercoagulability
Deep Venous Thrombosis and New Anticoagulants
Acute Coronary Syndrome: Two Drugs or Three
The New Anticoagulants: When to Use and Which One
Anticoagulation in Cerebrovascular Disease

Wonderful! He kept our doctors glued to their seats and overtime with questions. – Glendale Adventist Medical Center

Professor of Medical Oncology and Experimental Therapeutics
City of Hope National Medical Center

Advances in the Treatment of Later Stage Prostate Cancer


Co-Director of the Experimental Therapeutics Program
Associate Professor of Internal Medicine and Hematology Oncology
UT Southerwestern

Lung Cancer
Non-Small Cell Lung Cancer (NSCLC)


Professor and Chairman, Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center

Update on Breast Cancer
Personalized Approaches to Breast Cancer Screening, Detection and Treatment
New Developments in Therapy for Breast Cancer
The Latest on Personalized Cancer Treatment
Molecular Approaches and Targeted Therapies for Breast Cancer
Genetic Predisposition to Cancer
Integrative Medicine in Cancer


Associate Professor of Otolaryngology
Chief, Division of Head and Neck Surgery
City of Hope National Medical Center

HPV Associated Head & Neck Cancer: A Womans Perspective


Assistant Clinical Professor
City of Hope National Medical Center

Multiple Myeloma
Breast Cancer

As an oncologist, Gargi Upadhyaya, M.D., is especially interested in breast cancer, lymphoma and multiple myeloma. Her personal hobbies and interests include spending time with her family, including traveling all over the world and to India to visit her mother. She states, “Having cared for my grandmother and uncle with cancer I was motivated to become an oncologist who provides compassionate, family-centered care for my patients. The importance of family motivates my life, both inside and outside my practice.” Dr. Gargi has published articles in the Journal of Clinical Investigation, Blood, and Leukemia. She is an active member of the American Society of Clinical Oncology (ASCO).